This invention relates generally to methods, compositions and devices for removing arsenic from aqueous streams and is particularly concerned with methods, compositions and devices for removing arsenic from groundwater and drinking water using cerium in the +4 oxidation state to oxidize arsenic so it can be precipitated from the water.
Arsenic is a toxic element that naturally occurs in a variety of combined forms in the earth. Its presence in natural waters may originate, for example, from geochemical reactions, industrial waste discharges and past agricultural uses of arsenic-containing pesticides. Because the presence of high levels of arsenic may have carcinogenic and other deleterious effects on living organisms, the U.S. Environmental Protection Agency (EPA) and the World Health Organization have set the maximum contaminant level (MCL) for arsenic in drinking water at 10 parts per billion (ppb). Arsenic concentrations in wastewaters, groundwaters, surface waters and geothermal waters frequently exceed this level. Thus, the current MCL and any future decreases, which may be to as low as 2.0 ppb, create the need for new techniques to economically and effectively remove arsenic from drinking water, well water and industrial waters.
Arsenic occurs in four oxidation or valence states, i.e., −3, 0, +3, and +5. Under normal conditions arsenic is found dissolved in aqueous or aquatic systems in the +3 and +5 oxidation states, usually in the form of arsenite (AsO3−1) and arsenate (AsO4−3). The effective removal of arsenic by coagulation techniques requires the arsenic to be in the arsenate form. Arsenite, in which the arsenic exists in the +3 oxidation state, is only partially removed by adsorption and coagulation techniques because its main form, arsenious acid (HAsO3), is a weak acid and remains un-ionized at a pH between 5 and 8 where adsorption takes place most effectively.
Various technologies have been used in the past to remove arsenic from aqueous systems. Examples of such techniques include adsorption on high surface area materials, such as alumina and activated carbon, ion exchange with anion exchange resins, co-precipitation and electrodialysis. However, most technologies for arsenic removal are hindered by the difficulty of removing arsenite. The more successful techniques that have been used in large municipal water supplies are not practical for residential applications because of space requirements and the need to use dangerous chemicals. The two most common techniques for residential water treatment have been reverse osmosis and activated alumina. The former method produces arsenic-containing waste streams that must be disposed of, and the latter requires the use of caustic chemicals.
The above facts coupled with the potential for the decrease in MCL to between 2 and 10 ppb make it imperative that effective processes, compositions and devices for removing arsenic from water and other aqueous systems be developed.
In accordance with the invention, it has now been found that arsenic can be efficiently and effectively removed from water and other aqueous feedstocks by treating the arsenic-containing aqueous feed with a compound containing cerium in the +4 oxidation state, preferably cerium dioxide (CeO3), in order to oxidize the arsenic so that it can be more easily removed by precipitation from the treated aqueous feed to produce a purified aqueous liquid with a reduced concentration of arsenic. “Precipitation” as used herein encompasses not only the removal of arsenic-containing ions in the form of insoluble species, but also includes the immobilization of arsenic-containing ions on or in insoluble particles. In one embodiment of the process of the invention, water or other aqueous liquid containing dissolved arsenic in the +3 and +5 oxidation states is contacted with cerium dioxide to oxidize arsenic in the +3 oxidation state to arsenic in the +5 oxidation state, and the arsenic in the +5 oxidation state is removed from the aqueous liquid by contacting the liquid with a precipitating agent that reacts with the arsenic in the +5 oxidation state to produce insoluble arsenic compounds and an aqueous liquid of reduced arsenic content.
Typically, the oxidized arsenic is in the +5 oxidation state and dissolved in the water or other aqueous liquid in the form of arsenate (AsO4−3 ). The precipitating agent used to remove the oxidized arsenic from the aqueous liquid can be anything that reacts with the arsenate or other form of oxidized arsenic to produce insoluble arsenic compounds. For example, the precipitating agent can be cerium in the +3 oxidation state produced in the arsenic oxidation step when cerium in the +4 oxidation state is reduced. Alternatively, the precipitating agent can be any particulate solid containing cations in the +3 oxidation state, such as alumina, aluminosilicates, ion exchange resin and clays.
The oxidation and precipitation steps can be carried out in the same or separate zones. If the steps are carried out in the same zone, the compound containing cerium in the +4 oxidation state is usually mixed with the precipitating agent. Although this mixture can be made by supporting the cerium compound on the surface and/or in the pores of the precipitating solids, it is usually preferred that the cerium compound in particulate form be physically mixed with particles of the precipitating agent. A preferred composition of the invention comprises a mixture of cerium dioxide and alumina.
In a preferred embodiment of the process of the invention, an aqueous liquid containing dissolved arsenic in the from of arsenate and arsenite is contacted with a mixture of cerium dioxide particulates and alumina particulates in an oxidation zone such that the cerium dioxide oxidizes the arsenite to arsenate and the alumina reacts with the arsenate to form insoluble aluminum arsenate that sorbs onto the particles of alumina. The aqueous liquid exiting the oxidation zone contains a substantially reduced concentration of arsenic, usually less than about 2.0 ppb.
In one embodiment, the rare earth composition is essentially devoid of lanthanum.
In one embodiment, the rare earth composition is essentially free of all rare earths except cerium.
Although the process of the invention is primarily envisioned for removing dissolved arsenic from drinking water and groundwater, it will be understood that the process can be used to treat any aqueous liquid feed that contains undesirable amounts of arsenic. Examples of such liquid feeds include, among others, well water, surface waters, such as water from lakes, ponds and wetlands, agricultural waters, wastewater from industrial processes, and geothermal fluids. The arsenic-containing feed can also contain other inorganic contaminants, such as selenium, cadmium, lead and mercury, and certain organic contaminants. Generally, the process of the invention can be used to treat any aqueous liquid feedstock containing more than 2.0 ppb arsenic and is effective for treating feeds containing more than 500 ppb arsenic. The process is effective in decreasing the arsenic levels in such feeds to below 5.0 ppb, usually to below 2.0 ppb.
The arsenic contaminating the aqueous feed is normally dissolved in the aqueous phase and usually exists in both the +3 and +5 oxidation states, respectively, as arsenite (AsO3−1) and arsenate (AsO4−1). Techniques for removing arsenate exist and are quite effective, but removing the arsenite is a more difficult proposition because the present technologies for doing so are not greatly effective. It has now been found that substantially all of the dissolved arsenite can be easily oxidized to arsenate by treating the aqueous feed with cerium in the +4 oxidation state and the resulting arsenate, along with the arsenate originally present in the aqueous feed, precipitated from the treated feed to produce an arsenic-depleted aqueous liquid.
In the process of the invention, the aqueous feed contaminated with arsenic is passed through an inlet into an oxidation vessel at a temperature and pressure, usually ambient conditions, such that the water in the feed remains in the liquid state. If the feed is contaminated with particulate solids, it is usually treated to remove the solids before it is passed into the oxidation vessel. Any liquid-solids separation technique, such as filtration, centrifuging and hydrocycloning, can be used to remove the particulate solids.
In the oxidation vessel the aqueous feed is contacted with a compound containing cerium in the +4 oxidation state (hereinafter referred to as cerium, +4), which Ce +4 is an extremely strong oxidizing agent and oxidizes any arsenite or other arsenic present in the +3 oxidation state to arsenate or other species containing arsenic in the +5 oxidation state. All of the arsenic species containing arsenic in the +5 oxidation state is then precipitated from the aqueous phase by contacting the oxidized aqueous feed with a precipitating agent.
The oxidizing agent can be any solid or liquid containing cerium in the +4 oxidation state. Although it is generally preferred to use solid particles of cerium dioxide, which are insoluble in water and relatively attrition resistant as the oxidizing agent, water-soluble cerium compounds can also be used. Examples of such compounds include ceric ammonium nitrate, ceric ammonium sulfate, ceric sulfate, and ceric nitrate.
The precipitating agent that reacts with the arsenate containing arsenic in the +5 oxidation state to form insoluble arsenic compounds can be present in the oxidation vessel with the cerium +4 compound so that the precipitation occurs essentially simultaneously with the oxidation. Alternatively, it can be in a separate vessel into which the treated liquid exiting the oxidation vessel passes. For simplicity purposes, it is normally preferred for both the cerium compound and precipitating agent to be present in the oxidation vessel. This embodiment of the invention eliminates the need for an extra vessel and thereby reduces the cost of installing and operating the process of the invention.
Although the precipitating agent can be any material, solid or liquid, that reacts with arsenate or other species containing arsenic in the +5 oxidation state to form insoluble arsenic compounds, it is usually a particulate solid that contains cations in the +3 oxidation state, which cations react with arsenate to form insoluble arsenate compounds. Examples of such solids containing cations in the +3 oxidation state include alumina, gamma-alumina, activated alumina, acidified alumina such as alumina treated with hydrochloric acid, metal oxides containing labile anions such as aluminum oxychloride, crystalline alumino-silicates such as zeolites, amorphous silica-alumina, ion exchange resins, clays such as montmorillonite, ferric sulfate, porous ceramics, and cerium compounds containing cerium in the +3 oxidation state, such as cerous carbonate. Although lanthanum oxide and other rare earth compounds can be used as the precipitating agent, these materials are typically not employed (except of course for cerium compounds) in the process of the invention because it is preferred to use a precipitating agent that has a much smaller Ksp than that of the rare earth compounds.
As mentioned above it is normally preferable that the cerium +4 compound and precipitating agent both be present in the oxidation vessel so that the arsenic is oxidized and precipitated essentially simultaneously in the same vessel. Although the cerium +4 compound and precipitating agent can both be water-soluble, it is normally preferred that the cerium +4 compound and precipitating agent both be water-insoluble particulate solids that are either slurried with the aqueous feed in the oxidation vessel or physically mixed together in a fixed bed through which the aqueous feed is passed during the oxidation step. In an alternative embodiment of the invention, the cerium +4 compound can be deposited on the surface and/or in the pores of the solid precipitating agent. This embodiment is normally not preferred over a physical mixture because supporting the cerium compound on or in the precipitating solids requires the cerium compound to be dissolved in a liquid, the resultant solution mixed with the support solids, and the wet solids dried. Such steps add significantly to the cost of practicing the process of the invention.
Normally, a sufficient amount of the cerium +4 compound is present in the oxidation vessel with the particulate precipitating agent so that the mixture of the two contains between about 8 and 60 weight percent of the cerium +4 compound calculated as the oxide. Preferably, the mixture will contain between about 10 and 50 weight percent, more preferably between about 20 and 30 weight percent, of the cerium +4 compound calculated as the oxide. However, in some instances, it may be desirable for the mixture to contain greater than 40 to 45 weight percent of the cerium +4 compound calculated as the oxide.
Regardless of whether the cerium +4 compound is present in the oxidation vessel in admixture with the particulate precipitating agent or supported on or in the pores of the precipitating agent, the solids will typically range in diameter between about 0.25 and 1.5, preferably from 0.5 to 1.0, millimeters. When the cerium +4 compound and precipitating agent are present in the oxidation zone as a fixed bed, it is normally preferred that the particles be spherical in shape so the flow of the aqueous feed through the bed is evenly distributed. However, if desired, the particles may take other shapes including that of extrudates. Such extrudates would typically have a length between about 0.2 and about 3.0 millimeters.
During the oxidation step of the process of the invention, arsenite in the aqueous feed is oxidized to arsenate according to the following equation:
Ce+4+AsO2−1→Ce+3+AsO4−3
As the cerium +4 oxidizes the arsenite, it is reduced to cerium in the +3 oxidation state, which then reacts with the arsenate formed during the oxidation step to produce insoluble cerium arsenate as shown in the following equation:
Ce−3+AsO4−3→CeAsO4 (solid)
Although theoretically there is enough cerium +3 formed by reduction of cerium +4 to react with all of the arsenate formed in the oxidation reaction to precipitate the arsenate, it is normally preferred that an additional precipitating agent be present. This agent, which can be a compound containing cerium +3, reacts with any unreacted arsenate to form an insoluble precipitate, which is removed from the aqueous feed to produce the desired arsenic-depleted aqueous liquid.
The oxidation step that takes place in the oxidation vessel is normally carried out at ambient pressure, at a temperature from about 4° to 100° C., preferably from about 5° to 40° C., and at a pH greater than about 3.0. The residence time of the aqueous feed in the oxidation vessel typically ranges from about 2.0 to about 30 minutes. When the cerium +4 compound and arsenic precipitant are both solid particulates and present together as a fixed bed in the oxidation vessel, the precipitated arsenic compounds will be sorbed by or otherwise associated with the solid particles of the precipitating agent so that the aqueous fluid exiting the oxidation vessel will contain essentially no solids and very little arsenic, usually less than about 10 ppb and quite frequently less than 2.0 ppb. If the precipitating agent is not in the oxidation vessel, the effluent from the vessel is passed to another vessel where it is treated separately with the arsenic precipitating agent. Finally, if the cerium +4 compound and precipitating agent are particulate solids that are slurried with the aqueous feed in the oxidation vessel, the effluent from the vessel is normally treated to separate the solids, including the insoluble arsenic compounds formed in the vessel, from the arsenic-depleted liquid. Although the separation can be carried out in any type of device capable of removing particulates from liquids, a filtration system is typically employed.
If the aqueous feed to the process of the invention contains other contaminants that must be removed in addition to arsenic to produce the desired purified aqueous product, the removal of these contaminants is typically carried either before or after the oxidation step. If the other contaminants will interfere with the oxidation of the arsenic, they should be removed prior to the oxidation step. In some cases the process of the invention is also effective for removing other contaminants from the aqueous feed in addition to or to the exclusion of arsenic.
In a preferred embodiment of the invention, an arsenic purifying device containing a cartridge or filter is used to treat residential drinking water. The treating device can be a free standing container with a filtering device containing the composition of the invention or a cartridge type device designed to fit under a sink. These devices are situated so that the water entering the home or business location passes through the filter or cartridge before it enters the sink faucet. The filter and cartridge devices are quite simple and comprise a inlet attached to the source of the drinking water, a filter or cartridge containing the cerium +4 oxidizing agent, usually in the form of a fixed bed and in admixture with an arsenic precipitant, and an outlet in communication with the sink faucet to direct the arsenic-depleted drinking water exiting the cartridge or filter to the entrance of the faucet. Alternatively, a cartridge or filter type device can be designed to fit onto the faucet so that water exiting the faucet passes through the cartridge or filter device before it is consumed.
In the filter or cartridge, arsenic in the +3 oxidation state is oxidized to arsenic in the +5 oxidation state, and substantially all of the dissolved arsenic +5 present reacts with cerium in the +3 oxidation state and the arsenic precipitating agent to form insoluble arsenic compounds that are sorbed onto the fixed bed solids. The precipitating agent is preferably alumina or an ion exchange resin. The effluent exiting the fixed bed and the outlet of the cartridge or filter device will typically have an arsenic concentration less than about 2.0 ppb. After the fixed bed in one of the cartridge or filter devices becomes saturated with arsenic, the cartridge or filter is replaced with a new cartridge or filter of the same or similar design. The spent cartridge or filter is then disposed of in a legally approved manner.
In another embodiment, the process of the invention is used in community water treatment facilities to remove arsenic from drinking water before the water is distributed to local homes and businesses. For such use the cerium +4 oxidizing agent is typically present in large tanks in either slurry form or in a fixed bed so that relatively large amounts of arsenic-containing water can be treated either in a continuous or batch mode. The arsenic precipitant can be present either in the tank with the cerium +4 oxidizing agent or in a separate vessel fed by the effluent from the tank. The water exiting the process typically has an arsenic concentration less than about 10 ppb, usually less than 5.0 ppb, and preferably less than 2.0 ppb.
The nature and objects of the invention are further illustrated by the following example, which is provided for illustrative purposes only and not to limit the invention as defined by the claims. The example shows that arsenic in the +3 and +5 oxidation state can be completely removed from water using cerium dioxide.
Test solutions were prepared to mimic arsenic-containing groundwater by mixing certified standard solutions of arsenic in the +3 and +5 oxidation states with tap water containing no arsenic. Twenty grams of lanthanum oxide (La2O3), 20 grams of cerium dioxide (CeO2), and a mixture of 10 grams of lanthanum oxide and 10 grams of cerium dioxide were separately placed in a sealed 100 milliliter glass container and slurried with about 96 milliliters of test solutions containing 100 ppb of arsenic +3, 100 ppb of arsenic +5, and 50 ppb of both arsenic +3 and arsenic +5. The resultant slurries were agitated with a Teflon coated magnetic stir bar for 15 minutes. After agitation, the tap water was separated from the solids by filtration through Whatman #41 filter paper and sealed in 125 milliliter plastic sample bottles. The bottles were then sent to a certified drinking water analysis laboratory where the amount of arsenic in each sample was determined by graphite furnace atomic absorption spectroscopy. The results of these tests are set forth below in Table 1.
The data for test 3 in the table show that, when lanthanum oxide is used by itself, only 55 percent of the arsenic present in the arsenic-spiked tap water is removed. Since the solubility of lanthanum arsenate, which contains arsenic +5, is very small, it was assumed that the arsenic remaining in solution was primarily arsenic +3 in the form of arsenite. The results of test 4, on the other hand, show that cerium dioxide can remove all of the arsenic from the water. The disparity in these results is attributed to the fact that cerium exists in the +4 oxidation state in cerium dioxide and is a strong oxidizing agent, whereas the lanthanum in the lanthanum oxide, which is in the +3 oxidation state, is not an oxidizing agent. Although the lanthanum +3 reacts with arsenic in the +5 oxidation state to precipitate it from the water, the lanthanum does not react with the arsenic in the +3 oxidation state. The cerium in the cerium dioxide oxidizes the arsenic +3 to arsenic +5, which then reacts with cerium +3 formed by the reduction of cerium +4 to precipitate all of the arsenic dissolved in the water. Tests 5-7 show that equal mixtures of cerium dioxide and lanthanum oxide are also effective in removing all of the arsenic from the tap water.
Although this invention has been described by reference to several embodiments of the invention, it is evident that many alterations, modifications and variations will be apparent to those skilled in the art in light of the foregoing description. Accordingly, it is intended to embrace within the invention all such alternatives, modifications and variations that fall within the spirit and scope of the appended claims.
This application is a divisional application of U.S. Ser. No. 11/435,697, filed May 16, 2006, now pending, which was a divisional of U.S. Ser. No. 11/029,257, filed Jan. 5, 2005, now U.S. Pat. No. 7,048,853, which was a divisional application of U.S. patent application Ser. No. 10/353,705, filed on Jan. 29, 2003, now U.S. Pat. No. 6,863,825.
Number | Name | Date | Kind |
---|---|---|---|
1739840 | Kendall | Dec 1929 | A |
3194629 | Dreibelbis et al. | Jul 1965 | A |
3658724 | Stiles | Apr 1972 | A |
3768989 | Goetzinger et al. | Oct 1973 | A |
3849537 | Allgulin | Nov 1974 | A |
3865728 | Abbott et al. | Feb 1975 | A |
3916585 | Barks | Nov 1975 | A |
3956118 | Kleber et al. | May 1976 | A |
4001375 | Longo | Jan 1977 | A |
4046687 | Schulze | Sep 1977 | A |
4078058 | Fox | Mar 1978 | A |
4088754 | Monafo | May 1978 | A |
4094777 | Sugier et al. | Jun 1978 | A |
4096064 | Du Fresne | Jun 1978 | A |
4101631 | Ambrosini et al. | Jul 1978 | A |
4127644 | Norman et al. | Nov 1978 | A |
4200609 | Byrd | Apr 1980 | A |
4251496 | Longo et al. | Feb 1981 | A |
4346063 | Cahn et al. | Aug 1982 | A |
4386063 | Boden | May 1983 | A |
4404197 | Fox et al. | Sep 1983 | A |
4474580 | MacKenzie et al. | Oct 1984 | A |
4474896 | Chao | Oct 1984 | A |
4477315 | Tomaszewski | Oct 1984 | A |
4566975 | Allgulin | Jan 1986 | A |
4581229 | Petrow | Apr 1986 | A |
4596659 | Nomura et al. | Jun 1986 | A |
4622149 | Devuyst et al. | Nov 1986 | A |
4661330 | Chane-Ching et al. | Apr 1987 | A |
4714694 | Wan et al. | Dec 1987 | A |
4786483 | Audeh | Nov 1988 | A |
4814152 | Yan | Mar 1989 | A |
4818483 | Culling | Apr 1989 | A |
4828832 | De Cuellar et al. | May 1989 | A |
4843102 | Horton | Jun 1989 | A |
4849223 | Pratt | Jul 1989 | A |
4859432 | David et al. | Aug 1989 | A |
4881976 | Gradeff | Nov 1989 | A |
4891067 | Rappas et al. | Jan 1990 | A |
4917875 | Moore et al. | Apr 1990 | A |
4920195 | Kankare et al. | Apr 1990 | A |
4935146 | O'Neill et al. | Jun 1990 | A |
4946592 | Galaj et al. | Aug 1990 | A |
4968322 | Miyawaki et al. | Nov 1990 | A |
4973501 | Gradeff | Nov 1990 | A |
4997425 | Shioya et al. | Mar 1991 | A |
5004711 | Grodek | Apr 1991 | A |
5013534 | Dissaux et al. | May 1991 | A |
5024769 | Gallup | Jun 1991 | A |
5043072 | Hitotsuyanagi et al. | Aug 1991 | A |
5053139 | Dodwell et al. | Oct 1991 | A |
5061560 | Tajima et al. | Oct 1991 | A |
5064628 | Chane-Ching et al. | Nov 1991 | A |
5080926 | Porter et al. | Jan 1992 | A |
5082570 | Higgins et al. | Jan 1992 | A |
5104660 | Chvapil et al. | Apr 1992 | A |
5116620 | Chvapil et al. | May 1992 | A |
5126116 | Krause et al. | Jun 1992 | A |
5145587 | Ishii et al. | Sep 1992 | A |
5152936 | Tajima et al. | Oct 1992 | A |
5161385 | Schumacher | Nov 1992 | A |
5192452 | Mitsui et al. | Mar 1993 | A |
5207877 | Weinberg et al. | May 1993 | A |
5207995 | Bosserman | May 1993 | A |
5213779 | Kay et al. | May 1993 | A |
5227168 | Chvapil et al. | Jul 1993 | A |
5238488 | Wilhelm | Aug 1993 | A |
5260066 | Wood et al. | Nov 1993 | A |
5326737 | Kay et al. | Jul 1994 | A |
5330770 | Kuno | Jul 1994 | A |
5338460 | Yen | Aug 1994 | A |
5344479 | Kerfoot et al. | Sep 1994 | A |
5358643 | Mcclintock | Oct 1994 | A |
5368703 | Brewster | Nov 1994 | A |
5389352 | Wang | Feb 1995 | A |
5409522 | Durham et al. | Apr 1995 | A |
5433931 | Bosserman | Jul 1995 | A |
5500198 | Liu et al. | Mar 1996 | A |
5505766 | Chang | Apr 1996 | A |
5556545 | Volchek et al. | Sep 1996 | A |
5575915 | Nakamura et al. | Nov 1996 | A |
5575919 | Santina | Nov 1996 | A |
5603838 | Misra et al. | Feb 1997 | A |
5649894 | White et al. | Jul 1997 | A |
5660802 | Archer et al. | Aug 1997 | A |
5683953 | Mills | Nov 1997 | A |
5688378 | Khoe et al. | Nov 1997 | A |
5689038 | Bartram et al. | Nov 1997 | A |
5711930 | Albers et al. | Jan 1998 | A |
5712218 | Chopin et al. | Jan 1998 | A |
5728404 | von Rheinbaben et al. | Mar 1998 | A |
5730995 | Shirono et al. | Mar 1998 | A |
5783057 | Tomita et al. | Jul 1998 | A |
5820966 | Krause et al. | Oct 1998 | A |
5859064 | Cronce | Jan 1999 | A |
5897675 | Mangold et al. | Apr 1999 | A |
5897781 | Dourdeville | Apr 1999 | A |
5910253 | Fuerstenau et al. | Jun 1999 | A |
5914287 | Saito | Jun 1999 | A |
5918555 | Winegar | Jul 1999 | A |
5922926 | Back et al. | Jul 1999 | A |
5928504 | Hembre et al. | Jul 1999 | A |
5994260 | Bonneau | Nov 1999 | A |
6001152 | Sinha | Dec 1999 | A |
6001157 | Nogami | Dec 1999 | A |
6030537 | Shaniuk et al. | Feb 2000 | A |
6048821 | Demmel et al. | Apr 2000 | A |
6093328 | Santina | Jul 2000 | A |
6099819 | Srinivas et al. | Aug 2000 | A |
6114038 | Castro et al. | Sep 2000 | A |
6132623 | Nikolaidis et al. | Oct 2000 | A |
6136749 | Gadkaree et al. | Oct 2000 | A |
6143318 | Gilchrist et al. | Nov 2000 | A |
6146539 | Mills | Nov 2000 | A |
6177015 | Blakey et al. | Jan 2001 | B1 |
6180016 | Johnston et al. | Jan 2001 | B1 |
6187192 | Johnston et al. | Feb 2001 | B1 |
6197201 | Misra et al. | Mar 2001 | B1 |
6197204 | Heskett | Mar 2001 | B1 |
6200482 | Winchester et al. | Mar 2001 | B1 |
6203709 | Min et al. | Mar 2001 | B1 |
6214238 | Gallup | Apr 2001 | B1 |
6221118 | Yoshida et al. | Apr 2001 | B1 |
6221602 | Barbera-Guillem et al. | Apr 2001 | B1 |
6224898 | Balogh et al. | May 2001 | B1 |
6258334 | Gadkaree et al. | Jul 2001 | B1 |
6294006 | Andou | Sep 2001 | B1 |
6299851 | Li et al. | Oct 2001 | B1 |
6312604 | Denkewicz et al. | Nov 2001 | B1 |
6319108 | Adefris et al. | Nov 2001 | B1 |
6326326 | Feng et al. | Dec 2001 | B1 |
6341567 | Robertson et al. | Jan 2002 | B1 |
6350383 | Douglas | Feb 2002 | B1 |
6368510 | Friot | Apr 2002 | B2 |
6372003 | Kasai et al. | Apr 2002 | B1 |
6383273 | Kepner et al. | May 2002 | B1 |
6383395 | Clarke et al. | May 2002 | B1 |
6391869 | Parks et al. | May 2002 | B1 |
6395659 | Seto et al. | May 2002 | B2 |
6395736 | Parks et al. | May 2002 | B1 |
6403653 | Hobson et al. | Jun 2002 | B1 |
6420434 | Braue et al. | Jul 2002 | B1 |
6428705 | Allen et al. | Aug 2002 | B1 |
6444143 | Bawendi et al. | Sep 2002 | B2 |
6460535 | Nisewander et al. | Oct 2002 | B1 |
6461535 | de Esparza | Oct 2002 | B1 |
6475451 | Leppin et al. | Nov 2002 | B1 |
6524487 | Kulperger et al. | Feb 2003 | B2 |
6524540 | Heinig | Feb 2003 | B1 |
6528451 | Brezny et al. | Mar 2003 | B2 |
6536672 | Outwater | Mar 2003 | B1 |
6537382 | Bartram et al. | Mar 2003 | B1 |
6542540 | Leung et al. | Apr 2003 | B1 |
6562092 | Ito et al. | May 2003 | B1 |
6569224 | Kerfoot et al. | May 2003 | B2 |
6569393 | Hoke et al. | May 2003 | B1 |
6576092 | Granite et al. | Jun 2003 | B2 |
6599428 | Douglas | Jul 2003 | B1 |
6599429 | Azizian | Jul 2003 | B1 |
6602111 | Fujie et al. | Aug 2003 | B1 |
6602671 | Bawendi et al. | Aug 2003 | B1 |
6610264 | Buchanan et al. | Aug 2003 | B1 |
6613230 | Krulik et al. | Sep 2003 | B2 |
6627632 | Parks et al. | Sep 2003 | B2 |
6653519 | Koper et al. | Nov 2003 | B2 |
6680211 | Barbera-Guillem et al. | Jan 2004 | B2 |
6689178 | Ito et al. | Feb 2004 | B2 |
6706082 | Ota et al. | Mar 2004 | B2 |
6706195 | Jensen et al. | Mar 2004 | B2 |
6716895 | Terry | Apr 2004 | B1 |
6719828 | Lovell et al. | Apr 2004 | B1 |
6723349 | Hill et al. | Apr 2004 | B1 |
6770483 | Lyon | Aug 2004 | B2 |
6774361 | Bawendi et al. | Aug 2004 | B2 |
6780332 | Shiau et al. | Aug 2004 | B2 |
6790363 | Vempati | Sep 2004 | B2 |
6790420 | Breen et al. | Sep 2004 | B2 |
6800204 | Harck et al. | Oct 2004 | B2 |
6808692 | Oehr | Oct 2004 | B2 |
6821434 | Moore et al. | Nov 2004 | B1 |
6824690 | Zhao et al. | Nov 2004 | B1 |
6827766 | Carnes et al. | Dec 2004 | B2 |
6833123 | Huang et al. | Dec 2004 | B2 |
6843617 | Chowdhury et al. | Jan 2005 | B2 |
6843923 | Morton | Jan 2005 | B2 |
6846432 | Mills | Jan 2005 | B2 |
6849187 | Shaniuk | Feb 2005 | B2 |
6852903 | Brown et al. | Feb 2005 | B1 |
6855665 | Blake et al. | Feb 2005 | B1 |
6858147 | Dukhin et al. | Feb 2005 | B2 |
6861002 | Hughes | Mar 2005 | B2 |
6862825 | Lowndes | Mar 2005 | B1 |
6863825 | Witham et al. | Mar 2005 | B2 |
6864213 | Labarge et al. | Mar 2005 | B2 |
6881424 | Kemp et al. | Apr 2005 | B1 |
6881766 | Hain | Apr 2005 | B2 |
6887566 | Hung et al. | May 2005 | B1 |
6901684 | Ito et al. | Jun 2005 | B2 |
6905527 | Ito et al. | Jun 2005 | B2 |
6908560 | Guter | Jun 2005 | B2 |
6908570 | Green | Jun 2005 | B2 |
6908628 | Herruzo | Jun 2005 | B2 |
6914034 | Vo | Jul 2005 | B2 |
6919029 | Meng et al. | Jul 2005 | B2 |
6927501 | Baarman et al. | Aug 2005 | B2 |
6942840 | Broderick | Sep 2005 | B1 |
6946076 | Mills | Sep 2005 | B2 |
6946578 | Nakano et al. | Sep 2005 | B2 |
6957743 | Johnston et al. | Oct 2005 | B2 |
6960329 | Sellakumar | Nov 2005 | B2 |
6974564 | Biermann et al. | Dec 2005 | B2 |
6986798 | Bessho et al. | Jan 2006 | B2 |
6987129 | Mak et al. | Jan 2006 | B2 |
7008559 | Chen | Mar 2006 | B2 |
7033419 | Granite et al. | Apr 2006 | B1 |
7048853 | Witham et al. | May 2006 | B2 |
7048860 | Oishi | May 2006 | B2 |
7060233 | Srinivas et al. | Jun 2006 | B1 |
7067294 | Singh et al. | Jun 2006 | B2 |
7074336 | Teter et al. | Jul 2006 | B1 |
7094383 | Wang et al. | Aug 2006 | B2 |
7101415 | Torres et al. | Sep 2006 | B2 |
7101493 | Colucci | Sep 2006 | B2 |
7112237 | Zeller et al. | Sep 2006 | B2 |
7129684 | Park | Oct 2006 | B2 |
7141227 | Chan | Nov 2006 | B2 |
7160505 | Belbachir et al. | Jan 2007 | B2 |
7179849 | Terry | Feb 2007 | B2 |
7183235 | Lovell et al. | Feb 2007 | B2 |
7186671 | Smith et al. | Mar 2007 | B2 |
7192602 | Fechner et al. | Mar 2007 | B2 |
7211320 | Cooper et al. | May 2007 | B1 |
7241629 | Dejneka et al. | Jul 2007 | B2 |
7252694 | Woo et al. | Aug 2007 | B2 |
7252769 | Dickinson | Aug 2007 | B2 |
7279129 | Lanz et al. | Oct 2007 | B2 |
7282153 | Barrett et al. | Oct 2007 | B2 |
7291272 | Bourke et al. | Nov 2007 | B2 |
7291315 | Obee et al. | Nov 2007 | B2 |
7300589 | Witham et al. | Nov 2007 | B2 |
7311842 | Kim | Dec 2007 | B2 |
7335622 | Koyanaka et al. | Feb 2008 | B2 |
7335808 | Koper et al. | Feb 2008 | B2 |
7338603 | McNew et al. | Mar 2008 | B1 |
7361279 | Hernandez et al. | Apr 2008 | B2 |
7368412 | Tranter et al. | May 2008 | B2 |
7422759 | Kepner et al. | Sep 2008 | B2 |
7431758 | Ota et al. | Oct 2008 | B2 |
7445718 | Misra et al. | Nov 2008 | B2 |
7459086 | Gaid | Dec 2008 | B2 |
7473474 | Toreki et al. | Jan 2009 | B2 |
7476311 | Litz et al. | Jan 2009 | B2 |
20010009831 | Schink et al. | Jul 2001 | A1 |
20010012856 | Parks et al. | Aug 2001 | A1 |
20020003116 | Golden | Jan 2002 | A1 |
20020005382 | Kulperger et al. | Jan 2002 | A1 |
20020044901 | Wilson et al. | Apr 2002 | A1 |
20020072522 | Parks et al. | Jun 2002 | A1 |
20020187990 | Parks et al. | Dec 2002 | A1 |
20020198136 | Mak et al. | Dec 2002 | A1 |
20030015467 | Johnston et al. | Jan 2003 | A1 |
20030133990 | Hursey et al. | Jul 2003 | A1 |
20030149406 | Martineau et al. | Aug 2003 | A1 |
20030156981 | Mills | Aug 2003 | A1 |
20030215378 | Zhou et al. | Nov 2003 | A1 |
20040031764 | Heinig | Feb 2004 | A1 |
20040050795 | Park et al. | Mar 2004 | A1 |
20040230086 | Okun et al. | Nov 2004 | A1 |
20050069464 | Obee et al. | Mar 2005 | A1 |
20050098503 | Kim | May 2005 | A1 |
20050136486 | Haushalter | Jun 2005 | A1 |
20050159307 | Okun et al. | Jul 2005 | A1 |
20050230659 | Hampden-Smith et al. | Oct 2005 | A1 |
20050257724 | Guinther et al. | Nov 2005 | A1 |
20060030622 | Mak et al. | Feb 2006 | A1 |
20060049091 | Cheetham et al. | Mar 2006 | A1 |
20060070947 | Conrad | Apr 2006 | A1 |
20060120930 | Mizukami | Jun 2006 | A1 |
20060198883 | Parks et al. | Sep 2006 | A1 |
20060228275 | Rutman | Oct 2006 | A1 |
20060237369 | Kirts et al. | Oct 2006 | A1 |
20060254930 | Martinie et al. | Nov 2006 | A1 |
20070012631 | Coffey et al. | Jan 2007 | A1 |
20070017871 | Reddy et al. | Jan 2007 | A1 |
20070080115 | Sylvester | Apr 2007 | A1 |
20070081931 | Cho et al. | Apr 2007 | A1 |
20070122327 | Yang et al. | May 2007 | A1 |
20070149405 | Spitler et al. | Jun 2007 | A1 |
20070158251 | Chau | Jul 2007 | A1 |
20070169626 | Sullivan | Jul 2007 | A1 |
20080156734 | Burba et al. | Jul 2008 | A1 |
20090107919 | Burba et al. | Apr 2009 | A1 |
20090107925 | Burba et al. | Apr 2009 | A1 |
20090111689 | Burba | Apr 2009 | A1 |
20090112043 | Burba et al. | Apr 2009 | A1 |
Number | Date | Country |
---|---|---|
1248486 | Mar 2000 | CN |
0541158 | May 1993 | EP |
0939431 | Jan 1999 | EP |
1201607 | Feb 2002 | EP |
1071500 | Feb 2005 | EP |
2426469 | Nov 2006 | GB |
1151917 | Jun 1989 | JP |
10165948 | Jun 1998 | JP |
11090413 | Apr 1999 | JP |
11302684 | Nov 1999 | JP |
2000024647 | Jan 2000 | JP |
2002205062 | Jul 2002 | JP |
2002349234 | Dec 2002 | JP |
2004050069 | Feb 2004 | JP |
2004057870 | Feb 2004 | JP |
2004305915 | Nov 2004 | JP |
2004330012 | Nov 2004 | JP |
2005028312 | Feb 2005 | JP |
2005048181 | Feb 2005 | JP |
2005288363 | Oct 2005 | JP |
2006320847 | Nov 2006 | JP |
07081932 | Mar 2007 | JP |
WO 9511195 | Apr 1995 | WO |
0132799 | May 2001 | WO |
0132820 | May 2001 | WO |
WO 03092748 | Nov 2003 | WO |
WO 2004076770 | Sep 2004 | WO |
2004096433 | Nov 2004 | WO |
WO 2005028707 | Mar 2005 | WO |
WO 2005042130 | May 2005 | WO |
WO 2005075000 | Aug 2005 | WO |
WO 2005081722 | Sep 2005 | WO |
WO 2006011764 | Feb 2006 | WO |
WO 2006047613 | May 2006 | WO |
WO 2006070153 | Jul 2006 | WO |
WO 2007011877 | Jan 2007 | WO |
WO 2007120910 | Oct 2007 | WO |
Number | Date | Country | |
---|---|---|---|
20080093580 A1 | Apr 2008 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11435697 | May 2006 | US |
Child | 11925247 | US |